- Poster presentation
- Open Access
Success rate of an outreach PMTCT program in Nigeria
© Herbertson et al; licensee BioMed Central Ltd. 2014
- Published: 23 May 2014
- PMTCT Program
- Partner Institution
- Delivery Outcome
- Delivery Protocol
- Complete Delivery
Prevention of mother-to child transmission (PMTCT) of HIV is an important strategy to achieving zero new HIV infection and has been an important strategy in preventing the upsurge of HIV infection in Nigeria.
This study is an 8 year (2004 – 2012) review to evaluate the outcome of PMTCT outreach services offered by the Nigerian Institute of Medical Research (NIMR). It is a retrospective review of PMTCT and infant follow-up databases. PMTCT enrollees (from the NIMR adult antiretroviral clinic and referrals from public and private antenatal clinics) were placed on routine PMTCT care and subsequent infant prophylaxis, based on the WHO/National PMTCT guidelines. While ANC services are provided at the clinic, labor and delivery services are provided by partner institutions. The women are referred out at 36 weeks with delivery protocol. They are referred back after delivery with complete delivery summary form. Infants were followed up for 18 months and had HIV DNA PCR done at 6 weeks and 6 months.
There were a total of 4139 records for PMTCT uptake. 257 of these had incomplete data and were excluded from analysis. The delivery outcomes include: miscarriage -107 (2.8%); still birth- 134 (3.5%); live births -3641 (94%), neonatal deaths-68 (1.8%).Only 2623(73%) of the live births were presented at the clinic for follow up; of these, 21(0.8%) tested HIV positive by DNA at an average age of 12 weeks.
The PMTCT success rate of 99% achieved is comparable to that in developed countries. In low income countries where it is not possible to implement full PMTCT protocol, a strategy where a public institution is the center and provides services for other smaller institutions is recommended.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.